I. Industry Situation of the Company During the Reporting Period
(1) Material Science Industry
- Pharmaceutical Industry
In 2025, China's pharmaceutical industry will prioritize "high-quality development" as its main strategy, accelerating transformation. The industry is under comprehensive regulation, with green development frameworks guiding growth. The demand for biological drugs, traditional Chinese medicine, and agricultural research is increasing, while traditional pharmaceutical products face market pressures.
The industry is experiencing stable trends in 2025, with structural optimization being a key feature. In production and sales, the national "Agricultural Product Quality Improvement" policy continues to be implemented, promoting the sustainable development of the pharmaceutical industry. The industry is also focusing on product differentiation, quality, and cost management.
In terms of economic benefits, the industry is expected to see increased revenue and profit growth, with a focus on enhancing the core competitiveness of enterprises. The market dynamics will influence pricing strategies, and companies must adapt to changing market conditions.
(2) Trade Industry
The trade sector belongs to the commercial flow and service chain, experiencing various economic pressures. The industry is adapting to changes in consumer behavior and market demands, with a focus on enhancing service efficiency and supply chain management.
In recent years, the industry has faced challenges, including market competition and the need for digital transformation. The integration of online and offline sales channels is becoming increasingly important, as companies seek to enhance their market presence and operational efficiency.